Reaction
Medulloblastoma Recurrent reporting signals
As of the last recalculation, Medulloblastoma Recurrent appears in 113 FAERS reports alongside 5 co-occurring drug terms. The strongest observed disproportionality signal is THIOTEPA (PRR 283.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Thiotepa | 13 | 283.2 | 283.6 |
| Temozolomide | 23 | 252.2 | 252.4 |
| Etoposide | 40 | 154.6 | 154.7 |
| Somatropin | 21 | 64.4 | 64.5 |
| Vismodegib | 3 | 63.7 | 63.8 |